[Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil].
Florin
V
V
Vercambre-Darras
S
S
Piette
F
F
Mortier
L
L
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000368:Aged; D000634:Aminoquinolines / Q000008:administration & dosage*; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage*; D005500:Follow-Up Studies; D006801:Humans; D000077271:Imiquimod; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D013997:Time Factors; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D000077271:Imiquimod; D005472:Fluorouracil